Oral antiviral treatment for trigeminal neuralgia
Part of Brain & nervous system, Mouth & dental clinical trials.
This trial tests whether taking antiviral pills by mouth can help reduce pain from trigeminal neuralgia when no other cause is found. It may offer a new, simpler treatment option for people with this nerve pain condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with trigeminal neuralgia with no known cause
- You do not have another condition causing the pain, as confirmed by a brain scan
- You are generally healthy and do not have a severe illness or immune system problem
- You can understand and fill out questionnaires about your symptoms
- You are willing to take the study medication and follow the study plan
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether electroacupuncture (a treatment using gentle electrical pulses on thin needles) can help reduce the severe, shock-like facial pain of trigeminal neuralgia. It may offer an alternative or addition to your current medication.
This study tests whether electroacupuncture (a type of acupuncture with a mild electric current) can help reduce trigeminal neuralgia pain and improve the effects of your current medication. If you qualify, you might find a new way to manage your pain.
This trial tests a treatment called trigger point bloodletting for people with trigeminal neuralgia, a condition that causes severe facial pain. The treatment involves making small pricks on a specific spot on the upper lip to try to relieve the pain. It may help reduce pain intensity and improve quality of life.
This trial tests whether adding acupuncture (electroacupuncture) to the standard pain medicine pregabalin can better relieve facial shingles pain that started 1 to 3 months ago. It's for people with moderate pain who are willing to try both treatments together.
This trial is testing a medication called lacosamide, given through an IV, to treat sudden, severe facial pain attacks in people with trigeminal neuralgia who come to the emergency room. The goal is to see if it helps relieve pain quickly.
This trial tests a new drug called RP-008 combined with varenicline (a quit-smoking medication) to relieve severe facial pain from trigeminal neuralgia. If you've already tried standard pain medications without enough relief, this combination might help reduce your pain attacks.
Hear when a new Idiopathic Trigeminal Neuralgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.